SecBot SecBot
3 ·Filed Nov 19, 2026

MIST

Milestone Pharmaceuticals Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2d 12h ago SEC0001932659-26-000004
Form 3: initial insider ownership statement
Actionable Insight • Neutral

Routine initial ownership filing for a new finance officer. No trading activity or material change to the company's financial position. Monitor for any subsequent Form 4 filings that may indicate insider transactions.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Anthony J. Krick filed a Form 3 initial statement of beneficial ownership upon becoming Vice President, Finance of Milestone Pharmaceuticals. The filing discloses a grant of 100,000 employee stock options with a strike price of $1.32, vesting over four years. This is a routine insider filing with no material financial impact.

Key Facts

  • Anthony J. Krick appointed Vice President, Finance
  • Form 3 filed on 2026-11-19, reporting period 2026-11-10
  • Grant of 100,000 employee stock options at $1.32 strike price
  • Options vest 1/4 on May 7, 2027, then 1/36 monthly
  • Options expire July 1, 2036

Financial Impact

100,000 options at $1.32 strike, standard equity grant for a new officer

dilution

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001932659-26-000004
Document: 0001932659-26-000004-index-headers.html0001932659-26-000004
Document: 0001932659-26-000004-index.html0001932659-26-000004
Document: 0001932659-26-000004.txt0001932659-26-000004

Track record

13 reports on MIST

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +50.00% at T+20 after the Mar 20, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 20, 20261d ago SC 13G/A Neutral 4/10 Entry $0.3752 Now $0.3710 −1.12% settles Nov 30
  2. Nov 19, 20262d ago 3 Neutral 2/10 Viewing Entry $0.4130 Now $0.3710 −10.17% settles Nov 30
  3. Nov 13, 20268d ago 8-K Neutral 5/10 Entry $0.5200 to $0.3711 Now $0.3710 −28.65% ▼ −28.63% −20.08% vs SPY
  4. Oct 28, 202624d ago 8-K Bearish 7/10 Entry $0.7896 to $0.6925 Now $0.3710 +53.01% ▲ +12.30% +7.57% vs SPY
  5. Sep 3, 202611w ago 8-K Bullish 6/10 Entry $1.20 to $0.9494 Now $0.3710 −69.08% ▼ −20.88% −19.67% vs SPY
  6. Aug 21, 202613w ago Press Release Bullish 7/10 Entry $1.06 to $1.16 Now $0.3710 −64.83% ▲ +9.95% +9.48% vs SPY
  7. Aug 12, 202614w ago 8-K Bearish 6/10 Entry $1.13 to $1.08 Now $0.3710 +67.02% ▲ +4.00% +3.56% vs SPY
  8. May 26, 202625w ago EFFECT Bearish 6/10 Entry $1.40 to $1.32 Now $0.3710 +73.50% ▲ +5.71% +6.93% vs SPY
  9. May 13, 202627w ago S-3 Bearish 6/10 Entry $1.63 to $1.52 Now $0.3710 +77.24% ▲ +6.75% +6.03% vs SPY
  10. May 13, 202627w ago 8-K Neutral 5/10 No price data
Showing 10 of 13

US Market Status

Market Closed · Opens Mon (26h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 19, 2026